tirzepatide in nigeria MHRA grants authorisation for Lilly's weight loss drug Mounjaro TAVR-MET: Early Signs Point to
Description
Bretault M, Carette C, Zaharia R, et al
Knowing what to expect and how to handle these effects helps you stick with your treatment, which means better, lasting weight loss
Who Is Eligible for Tirzepatide Treatment
Accessed 11 Dec 2022
Rare: bradycardia, cerebral embolism, cerebral ischemia, extrasystoles, heart block, pallor, peripheral vascular disorder, phlebitis, shock, thrombophlebitis, thrombosis, vasospasm, ventricular arrhythmia, ventricular extrasystoles, ventricular fibrillation
It may also cause low blood sugar, especially if used with insulin or sulfonylureas, so regular meals and carrying a fast-acting sugar source are important
